Inspire Investing, LLC Puma Biotechnology, Inc. Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$7.01 - $13.24 $287 - $542	-41 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$6.28 - $14.57 $134,078 - $311,069	-21,350 Reduced 99.81%	41 $0
Q4 2019 Jan 24, 2020	BUY	$6.5 - $10.73 $35,711 - $58,950	5,494 Added 34.56%	21,391 $187,000
Q3 2019 Nov 13, 2019	BUY	$8.75 - $12.85 $32,007 - $47,005	3,658 Added 29.89%	15,897 $171,000
Q2 2019 Jul 16, 2019	BUY	$12.3 - $35.76 $150,539 - $437,666	12,239 New	12,239 $156,000
Q1 2018 Apr 13, 2018	SELL	$59.7 - $99.25 $35,223 - $58,557	-590 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$93.85 - $132.45 $55,371 - $78,145	590	590 $58,000

107

32.2M

43.4K

3.7K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $130M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.